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Adenovirus-mediated transfer of the 39 kD receptor-associated Mesothelial cells constitute the main cell population
protein increases fibrinolytic capacity. of the innermost surface of the peritoneal wall. In contin-
Background. The mesothelium has an important role in uous ambulatory peritoneal dialysis (CAPD), the meso-maintaining an adequate fibrinolytic capacity in the peritoneal
thelium is important for prevention of adhesions and forcavity and thus in preventing the formation of fibrinous perito-
local host defense [1].neal adhesions by secreting the fibrinolytic enzyme tissue-type
plasminogen activator (t-PA). The fibrinolytic activity of hu- The mesothelium has an important role in maintaining
man mesothelial cells (HMCs) is counteracted by rapid uptake an adequate fibrinolytic capacity in the peritoneal cavity
of t-PA via the low-density lipoprotein receptor-related protein by producing the fibrinolytic enzymes tissue-type and(LRP). The 39 kD receptor-associated protein (RAP) is an inhib-
urokinase-type plasminogen activator (t-PA and u-PA,itor of binding of t-PA to LRP, but RAP itself is also rapidly
respectively). t-PA and u-PA convert the inactive zymo-degraded via LRP.
Methods. Adenovirus-mediated RAP gene transfer technol- gen plasminogen into plasmin, which effects the degrada-
ogy was used to evaluate the effect of prolonged overexpression tion of fibrin. This plasma-independent fibrinolytic sys-
of RAP on t-PA accumulation in conditioned medium of
tem is crucial in the dissolution of fibrous exudates andHMCs under basal and inflammatory conditions.
in preventing the formation of fibrinous peritoneal adhe-Results. Infection of HMCs with a recombinant adenovirus
carrying the RAP cDNA resulted within one day in t-PA levels sions [2–5]. When the peritoneal fibrinolytic activity is
that were maximally twofold to threefold increased as compared insufficient, for example, during physical and/or chemical
with noninfected or adenovirus--galactosidase–infected cells. irritation of the peritoneum through CAPD, fibrin de-
Whereas upon prolonged incubation, t-PA levels in the condi-
posits may persist, and fibrinous adhesions can develop.tioned medium of uninfected cells leveled off because of rapid
Subsequently, these fibrinous adhesions become orga-uptake and degradation via LRP, t-PA concentrations in the
medium of adenovirus-RAP–infected cells continued to increase, nized, as characterized by deposition of collagen and
reaching fivefold control levels after 72 hours. The increased concomitant vascular in-growth, and the adhesions are
t-PA accumulation persisted for seven days and then slowly changed into permanent fibrous adhesions [6, 7]. In ac-
returned to control values over the next few weeks. In contrast,
cordance with the concept that persistent fibrin deposi-the production of a specific inhibitor of t-PA, plasminogen activa-
tion is due to insufficient fibrinolytic capacity, intraperi-tor inhibitor-1 (PAI-1), was not affected by adenoviral RAP gene
transfer. Northern blotting analysis showed that t-PA, PAI-1, and toneal application of exogenous initiators of fibrinolysis,
LRP mRNA concentrations were not changed after adenoviral such as recombinant t-PA and streptokinase, have suc-
infection, underlining that the elevated t-PA levels are the result cessfully been applied to diminish and prevent experi-
of RAP-blocked uptake and degradation of t-PA rather than
mentally induced peritoneal adhesions in animal modelsincreased t-PA synthesis. RAP gene transfer also restored dimin-
[8, 9]. Limitations and drawbacks of the administration ofished fibrinolytic activity of cytokine-treated mesothelial cells.
Conclusions. Adenovirus-mediated transfer of the RAP gene exogenous fibrinolytic agents, however, are the relatively
provides an efficient way of transiently increasing the fibrino- large amounts required, their transient time of action
lytic capacity of mesothelial cells. due to leakage from the cavity, and in the case of strepto-
kinase, the evoked immune response. An attractive alter-
native approach would be to increase the endogenousKey words: tissue-type plasminogen activator, mesothelial cells, perito-
neal cavity, CAPD, host defense, adhesion prevention, fibrin. fibrinolytic capacity of the peritoneal cavity in a regu-
lated way for a period of time sufficient to permit sub-Received for publication October 30, 2000
stantial tissue repair. Because mesothelial cells, particu-and in revised form January 23, 2001
Accepted for publication January 26, 2001 larly those lining the peritoneal cavity, represent an
attractive target for gene therapy [10–12], we started 2001 by the International Society of Nephrology
117
Goedde et al: RAP gene transfer into mesothelial cells118
experiments to explore the feasibility of a gene therapy Recombinant t-PA (Actilyze) was obtained from Boeh-
ringer Ingelheim (Ingelheim, Germany), and Ukidan two-strategy to increase the profibrinolytic properties of hu-
man mesothelial cells (HMCs). chain u-PA was purchased from Serono (Aubonne, Swit-
zerland). RAP was produced as a recombinant fusionRecently, we have described that the fibrinolytic activ-
ity of HMCs is not only counteracted by the release of a protein with Salmonella japonicum glutathione S-trans-
ferase (GST) and purified according to a combinationspecific inhibitor of t-PA and u-PA activity, plasminogen
activator inhibitor-1 (PAI-1), but also by rapid uptake of the methods described by Herz et al [15] and War-
shawsky, Bu, and Schwartz [16]. The GST-RAP plasmidand degradation of t-PA and u-PA from the medium via
receptor-mediated endocytosis [13]. This differs from was kindly provided by Dr. J. Herz (University of Texas
Southwestern Medical Center, Dallas, TX, USA). Bo-the plasma fibrinolytic system, in which one cell type
(vascular endothelial cells) secretes t-PA, and other cell vine serum albumin (BSA) and Tween 80 were pur-
chased from Sigma (St. Louis, MO, USA). Hybond-Ntypes (liver hepatocytes, endothelial cells, and Kupffer
cells) are responsible for clearance of t-PA from the filters, Hyperfilm MP, deoxycytidine 5[-32P] triphos-
phate (3 Ci/mol), and Na125I-iodine were obtainedblood stream. The major part of the binding and degrada-
tion of t-PA by the mesothelial cells was found to occur from Amersham Pharmacia Biotech (Buckinghamshire,
UK). Other materials used have been specified in thevia the low-density lipoprotein receptor-related protein
(LRP), and could be blocked almost completely by the Methods section or in the references cited therein.
addition of recombinant 39 kD receptor-associated pro-
Preparation of recombinant adenoviral vectorstein (RAP; an inhibitor of LRP). Endocytosis of u-PA
occurs via two different pathways. After binding to u-PA The recombinant adenoviral vectors expressing either
the RAP gene (Ad-RAP) or the -galactosidase genereceptor, a RAP-inhibitable and a non–RAP-inhibitable
route for u-PA degradation were demonstrated. How- (Ad--Gal) under the control of cytomegalovirus (CMV)
promoter were kindly provided by Drs. T. Willnow andever, RAP itself is also efficiently endocytosed via LRP,
J. Herz [17, 18]. The generation of these vectors and theresulting in rapid depletion of RAP from the medium
propagation and titration of the recombinant adenovirusand consequently only a temporary inhibition of t-PA
have been described previously [19]. For adenovirus in-and u-PA internalization. In the present study, we used
fection of cells, the crude virus preparations were sub-an adenovirus vector to carry a RAP cDNA into HMCs.
jected to two rounds of purification by cesium chlorideThe use of adenovirus gene transfer technology allowed
(CsCl) gradient centrifugation; HSA was added to 0.1%us to test the hypothesis that prolonged RAP overexpres-
(wt/vol) followed by extensive dialysis against a buffer ofsion would block LRP in a more sustained fashion and
25 mmol/L Tris-HCl, 137 mmol/L NaCl, 5 mmol/L KCl,cause long-term t-PA accumulation in the medium.
0.73 mmol/L Na2HPO4, 0.9 mmol/L CaCl2, 0.5 mmol/L
MgCl2, pH 7.45, at 4C. After dialysis, glycerol was addedMETHODS to 10% (vol/vol), and aliquots of the virus stocks were
M199 medium was obtained from Flow Laboratories frozen in liquid N2 and stored at80C. Routinely, virus
(Irvine, UK); tissue culture plastics were from Costar titers of the stocks varied from 1 to 5  1010 plaque-
(Cambridge, MA, USA). A crude preparation of endo- forming units (PFUs)/mL.
thelial cell growth factor was prepared from bovine brain
Cell culture experimentsas described by Maciag et al [14]. Human serum was
prepared from freshly collected blood of healthy donors Human peritoneal mesothelial cells were isolated from
and was pooled and stored at 4C; it was not heat inacti- the omental tissue of consenting patients undergoing
vated before use. Newborn calf serum was purchased elective surgery. Cells were grown in fibronectin-coated
from Life Technologies (Grand Island, NY, USA) and it dishes in M199 supplemented with 20 mmol/L HEPES,
was heat inactivated before use (30 min at 56C). Sterile, pH 7.4, 10% (vol/vol) human serum, 10% (vol/vol) heat-
pyrogen-free human serum albumin (HSA; 20% wt/vol) inactivated newborn calf serum, 150 g/mL endothelial
was from the Central Laboratory of the Netherlands cell growth factor, 2 mmol/L l-glutamine, 5 IU/mL hepa-
Red Cross Blood Transfusion Service (Amsterdam, The rin, 100 U/mL penicillin, and 100 g/mL streptomycin at
Netherlands). Collagenase type II was from Worthington 37C in a 5% CO2/95% air atmosphere. The medium was
(Freehold, NY, USA). Human fibronectin was a gift replaced every two to three days. Subcultures were ob-
from Dr. J.A. van Mourik (Central Laboratory of the tained by trypsin/ethylenediaminetetraacetic acid (EDTA)
Netherlands Red Cross Blood Transfusion Service, Am- treatment of confluent monolayers at a split ratio of 1:3.
sterdam, The Netherlands). Cells from omental tissue were pure mesothelial cells
Mouse monoclonal antibodies against cytokeratins 8 as assessed by their uniform cobblestone appearance at
and 18 and against vimentin were a gift from Dr. G. confluence, by the absence of von Willebrand factor, and
by the uniform positive staining for cytokeratins 8 andvan Muijen (University of Nijmegen, The Netherlands).
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18 and for vimentin [20]. For the experiments, confluent Western blot analysis
cultures were used at the second or third passage, and Western blot analysis was performed as described by
cells were always refed the day before the experiment Herz et al [15, 17].
with incubation medium: M199, supplemented with 20
Assaysmmol/L HEPES, pH 7.4, 10% (vol/vol) human serum,
2 mmol/L l-glutamine, and antibiotics. The assay of t-PA antigen was performed with the
Infection of cells was performed in 24-well dishes (2 enzyme-linked immunosorbent assay (ELISA) Throm-
cm2). To that end, cells were incubated with 200 L bonostika t-PA (Organon-Teknika, Turnhout, Belgium).
M199/2% (vol/vol) heat-inactivated newborn calf serum In this assay, free t-PA and t-PA:PAI-1 complexes were
containing Ad-RAP or Ad--Gal in concentrations rang- detected with equal efficiency. PAI-1 antigen was mea-
ing from 1  105 to 1  109 PFU/mL. After one hour, sured by ELISA (Imulyze) obtained from Biopool (Umea˚,
cells were washed twice with M199, and incubation me- Sweden). The ELISA kit for u-PA was from Taurus
dium (0.5 mL) was added. At different time points, con- (Kordia Laboratory Supplies, Leiden, The Netherlands).
ditioned media were collected and centrifuged for five The expression of -galactosidase after infection of
minutes at 8000 r.p.m. in a microfuge centrifuge to re- cells with Ad--Gal was analyzed by incubation of cells
move cells and cellular debris. For prolonged incuba- with 5-bromo-4-chloro-3-indolyl -D-galactoside (X-Gal;
tions, cells were refed every 24 hours unless stated other- Roche Diagnostics), following the protocol recommended
wise. Conditioned media were stored at20C until use. by the supplier. In short, cells were fixed in 2% (vol/vol)
The cells were used for isolation of RNA and Western formaldehyde, 0.2% (vol/vol) glutaraldehyde, 0.02%
blot analysis. (vol/vol) NP40 in phosphate-buffered saline (PBS) for
Each experiment shown represents cells isolated from 10 minutes at 4C and washed four times with ice-cold
one individual and is a representative experiment out of PBS containing 2 mmol/L MgCl2. The cells were then
at least three performed using cells isolated from differ- stained with 1 mg/mL X-Gal, 5 mmol/L potassium ferro-
ent individuals and using at least one other adenovirus cyanide, 5 mmol/L potassium ferricyanide, and 2 mmol/L
preparation. MgCl2 in PBS for 4 to 16 hours at 37C.
RNA isolation and Northern blotting Statistics
Total RNA was extracted from cells as described by Data are given as mean  SD. Statistical analysis was
Chomczynski and Sacchi [21]. RNA samples were dis- performed with the nonparametric Mann–Whitney U test,
solved in H2O, and the RNA concentration in each sample and a P value of less than 0.05 was considered significant.
was determined spectrophotometrically. Equal amounts of
RNA were analyzed for t-PA, u-PA, PAI-1, RAP, and
RESULTSglyceraldehyde-3-phosphate dehydrogenase (GAPDH)
Inhibition of t-PA degradation by adenoviral genemRNA content by Northern blot hybridization as out-
transfer of RAP to HMCslined previously [13]. In short, RNA samples were sub-
jected to gel electrophoresis in formaldehyde-agarose To assess the functional activity of Ad-RAP, we deter-
gels. After electrophoresis, RNA was transferred to Hy- mined the potency of the recombinant virus to enhance
bond-N according to the manufacturer’s instructions. t-PA accumulation in the medium of cultured HMCs.
Hybridization was usually performed at 62C with 1 ng/mL Figure 1A shows the amount of t-PA antigen in a 24-hour
probe labeled by random prime labeling to approxi- conditioned medium of HMCs preincubated for one
mately 2  108 cpm/g DNA. The membranes were hour with different concentrations of Ad-RAP, ranging
subsequently exposed to Amersham Hyperfilm-MP film from 105 to 109 PFU/mL. As compared with noninfected
with an intensifying screen at 80C. The RAP cDNA cells, t-PA accumulation in conditioned medium of in-
fragment used as probe in the hybridization experiments fected cells reached maximally twofold to threefold higher
was a 540 bp fragment (nucleotides 399 to 939). The levels at a virus concentration of 107 PFU/mL. Parallel
other cDNA probes have been described before [13]. experiments in which HMCs were incubated for 24 hours
Cell viability was assessed by the MTT assay (Roche in the presence of 1 mol/L exogenous GST-RAP re-
Diagnostics, Almere, The Netherlands), which is based sulted in t-PA antigen levels in the medium that were
on the cellular reduction of the tetrazolium salt MTT by approximately twofold higher relative to those of un-
mitochondrial dehydrogenase of viable cells to a blue treated control cultures (data not shown). Infection with
formazan product that can be measured spectrophoto- higher virus titers resulted in an almost linear decrease
metrically at 545 nm. Protein was measured using the in t-PA levels with increasing numbers of PFU of Ad-
Bradford protein assay (Bio-Rad Laboratories b.v., RAP added, resulting in t-PA concentrations far below
control t-PA levels. Infection with Ad--Gal showed aVeenendaal, The Netherlands).
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Fig. 1. Adenovirus-mediated transfer of receptor-associated protein
(Ad-RAP) leads to a dose-dependent increase in tissue-type plasmino-
gen activator (t-PA) accumulation in the conditioned medium of human
mesothelial cells (HMCs). HMCs were incubated with vehicle (control)
or infected with the indicated concentrations of Ad-RAP () or-galacto-
sidase (Ad--Gal; ) as described in the Methods section. At 24-hours
postinfection, the conditioned media were collected and assayed for
t-PA (A) and PAI-1 antigen (B), and cells were analyzed for infection
efficiency (as determined by cellular -galactosidase expression) and
cell viability (as assessed by the MTT assay) (C ). Data are expressed
as means  SD of three experiments in duplicate. *P 	 0.05 compared
with control.
qualitatively very similar profile of t-PA accumulation, The use of Ad--Gal enabled us to quantitate the
efficiency of adenovirus-mediated gene transfer toincluding a fall in t-PA levels at virus concentrations
higher than 107 PFU/mL. However, with Ad--Gal, max- HMCs. As shown in Figure 1C, maximum transduction
efficiency was reached at a virus concentration of 107imal increases in t-PA levels were only 15% above con-
trol levels. PFU/mL, a value that coincided with the concentration
at which maximal accumulation of t-PA in the mediumFor comparison, we also measured u-PA and PAI-1
accumulation under the various experimental conditions. was found.
For a quantitative evaluation of cell viability, the MTTIn agreement with previous findings [13], hardly any u-PA
antigen (	0.1 ng/105 cells) was detectable in the 24-hour test was performed. With both Ad-RAP and Ad--Gal,
virus titers of 
3  107 PFU/mL strongly decreased cellconditioned medium of HMCs incubated under control
conditions. After overexpressing RAP via adenovirus- viability (Fig. 1C), thus explaining the parallel fall in
t-PA (production) levels.mediated RAP gene transfer, u-PA antigen levels in the
medium increased nearly threefold (data not shown). In
Time course and stability of t-PA production incontrast to t-PA and u-PA, PAI-1 production was not
HMCs following infection with Ad-RAPsignificantly affected by preincubation of HMCs with
Ad-RAP (or Ad--Gal) at concentrations of up to 3  Next, the time course of t-PA antigen accumulation
in the conditioned media of HMCs infected with Ad-107 PFU/mL (Fig. 1B). Infection with higher virus titers
was found to decrease PAI-1 levels in a virus dose-depen- RAP or Ad--Gal was measured (Fig. 2A). To that end,
HMCs were preincubated for one hour with 107 PFU/mLdent manner, similar to that observed for t-PA.
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tinue to produce higher t-PA levels, 24-hour t-PA pro-
duction rates were determined during a 14-day incuba-
tion, with the medium refreshed every 24 hours (Fig. 2B).
High t-PA production rates (twofold over control val-
ues) in the Ad-RAP–infected HMCs were sustained for
at least seven days and then slowly declined, reaching
values approximately 40% above control levels after 14
days. This t-PA production rate profile of Ad-RAP–
infected HMCs resembled the-galactosidase activity pat-
tern of Ad--Gal–infected cells. Histochemical staining
for -galactosidase activity showed a high percentage
(
95%) of cells expressing high -galactosidase activity
for at least seven days, with the enzyme activity gradually
decreasing thereafter. The Ad--Gal–infected cells showed
increases in t-PA production of 20 to 50% above control
values during the 14-day monitoring period.
Specificity of Ad-RAP–induced increase
in t-PA accumulation
To determine whether the elevated t-PA production
in Ad-RAP-infected HMCs can be fully explained by
RAP overexpression and to learn more about the speci-
ficity of the technique, Northern blotting analyses were
performed to examine the expression of t-PA, PAI-1,
LRP, RAP, and tissue factor mRNAs in control and
adenovirus-infected HMCs (Fig. 3). Transcripts for t-PA
(2.5 kb), PAI-1 (3.2 and 2.4 kb), and LRP (15 kb) were
evident in HMCs before adenoviral infection, and
mRNA concentrations did not change after Ad-RAP or
Ad--Gal infection of the cells. A strong signal for RAP
mRNA (1.8 kb) was seen in only Ad-RAP–infected
Fig. 2. Time course of t-PA production and t-PA production rate fol- HMCs. No signal was detectable for the expression of
lowing infection of HMCs with Ad-RAP. HMCs were preincubated tissue factor, a marker of HMC activation [22], in eitherfor one hour with 107 PFU/mL Ad-RAP (, ), 107 PFU/mL Ad--
control or adenovirus-infected cells, indicating that theGal (,), or vehicle (,; control), and incubated for various periods
(A) up to 72 hours without refreshing the culture medium, or (B) for infection did not lead to a general activation of the cells.
14 days with the medium refreshed every 24 hours. These data shown The conclusion that the elevated t-PA levels in theare from one representative experiment of three performed, and are
conditioned medium of Ad-RAP-infected HMCs are theexpressed as means  SD. *P 	 0.05 compared with control.
result of RAP-blocked uptake and degradation of t-PA
via LRP rather than increased t-PA synthesis is further
supported by comparable experiments in cultured human
Ad-RAP, 107 PFU/mL Ad--Gal, or vehicle, and were umbilical vein endothelial cells (HUVECs). HUVECs
washed and incubated with incubation medium for various synthesize t-PA but lack significant LRP expression (T.
periods up to 72 hours without refreshing the medium. Kooistra, unpublished data) [23]. Ad-RAP–infected
Whereas in the conditioned media of control (that is, non- HUVECs showed a strong signal for RAP mRNA, but
infected cells) the t-PA antigen concentrations reached unlike HMCs, this did not result in significantly elevated
steady-state levels after approximately 24 hours of incu- t-PA levels (Fig. 4). It was found that HUVECs require
bation, the t-PA levels in the conditioned medium of approximately 10 times higher virus concentrations than
Ad-RAP-infected cells continued to increase during the HMCs to reach maximum infection efficiency, that is,
entire incubation period, resulting in threefold higher 
95% of the cells infected.
levels than the control after 48 hours and fivefold higher
Immunoblotting analysis of RAP in extracts andthan control levels after 72 hours. HMCs infected with an
conditioned medium of HMCsequivalent amount of Ad--Gal virus produced an al-
most twofold increase in t-PA accumulation as compared Endogenous RAP is an endoplasmic reticulum resi-
with control cells after both 48- and 72-hour incubations. dent protein and an intracellular chaperone for LRP
[24]. An important issue is whether overexpression ofTo evaluate how long the Ad-RAP–infected cells con-
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Fig. 4. Effect of Ad-RAP on t-PA accumulation in the conditioned
medium of HUVECs. HUVECs were incubated with vehicle (control)
or infected with the indicated concentrations of Ad-RAP () or Ad-
-Gal (). At 24 hours postinfection, the conditioned media were
collected and assayed for t-PA antigen. Maximal infection efficiency
(as determined by cellular -galactidose expression) was reached at a
virus concentration of 108 PFU/mL. Data are expressed as means 
SD of three experiments in duplicate. *P	 0.05 compared with control.
Western blotting in Figure 5 shows a strong 40 kD RAP
protein signal in cell extracts of HMCs at eight hours
after Ad-RAP infection, but only a weak signal in cell
extracts of uninfected or Ad--Gal infected HMCs.
These results are in line with the mRNA data shown in
Figure 3. Secretion of RAP into the medium of Ad-
RAP–infected HMCs became detectable 8 to 12 hoursFig. 3. Effect of Ad-RAP and Ad--Gal infection on t-PA, PAI-1,
LRP, RAP, and tissue factor (TF) mRNA expression in HMCs. HMCs after infection of the cells, but concentrations remained
were preincubated for one hour with 107 PFU/mL Ad-RAP, 107 PFU/mL relatively low. Our studies do not allow conclusions
Ad--Gal, or vehicle (control). Eight and 24 hours after adenoviral
about whether these RAP concentrations in the mediuminfection, total RNA was isolated and subjected to Northern blot analy-
sis using 32P-labeled probes for t-PA, PAI-1, LRP, RAP, TF, and are sufficient to prevent binding of t-PA to LRP on the
GAPDH. The latter was used as a loading control. No signal was cell surface.
detectable for TF. The size of the respective mRNA is indicated on
the right in kilobases (kb). Exposure times of the autoradiograph to
Ad-RAP infection as a tool to counteract t-PAHyperfilm-MP film were different and dependent on the actual signal.
This is a representative experiment out of the three performed. down-regulation under inflammatory conditions
Reduced peritoneal fibrinolytic capacity during sepsis
or inflammation can at least partly be explained by sup-
pressed t-PA expression [22]. To explore the possibilityRAP from the strong CMV promoter results in secretion
that diminished t-PA degradation might compensate forof RAP into the incubation medium and accumulates in
this decreased t-PA synthesis, we measured t-PA accu-concentrations sufficient to directly inhibit LRP on the
mulation in tumor necrosis factor- (TNF-; 1000 U/mL)-HMC cell surface. Implicitly, RAP levels in the condi-
or interleukin-1 (IL-1; 10 U/mL)-treated control andtioned medium rather than infection efficiency per se
Ad-RAP–infected HMCs (Fig. 6). Whereas IL-1 treat-would be the critical factor for preventing t-PA uptake
ment of control cells led to a 27% decrease in t-PA levels,and degradation. Alternatively, RAP overexpression
a similar treatment of Ad-RAP–infected cells resulted inmay have an effect on the intracellular pathway of LRP,
t-PA concentrations 82% above those of control, thatwhich could contribute to the observed functional block
is, untreated, noninfected cells. Similarly, the TNF-–of this receptor [25]. As a first approach to address this
evoked decrease in t-PA accumulation of 51% could alsoquestion, RAP concentrations in cell extracts and condi-
be counteracted by prior Ad-RAP infection, albeit thattioned media were analyzed by Western blotting at dif-
ferent time points after Ad-RAP infection of HMCs. t-PA levels remained slightly (17%) below control levels
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Fig. 5. Western analysis of RAP in cell ex-
tracts and conditioned medium of HMCs after
Ad-RAP infection. HMCs were preincubated
for one hour with 107 PFU/mL Ad-RAP, 107
PFU/mL Ad--Gal, or vehicle. At different
time points after adenoviral infection, condi-
tioned medium was collected. Eight and 24
hours after adenoviral infection, membrane
fragments were isolated from HMCs. Solubi-
lized membrane proteins and conditioned me-
dium were subjected to sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to a nitrocellulose
membrane, as described by Herz et al [15, 17].
As a positive control, site-specific protease-
cleaved GST-RAP was coelectrophoresed.
The filters were probed with anti-RAP immu-
noglobulin G (IgG; 5 g/mL), and bound IgG
was detected with 125I-labeled goat antibody
to rabbit IgG. The autoradiograph shown is
from a representative experiment out of the
three performed.
HMCs to increase the fibrinolytic activity of these cells
for a prolonged time. Our results demonstrate that infec-
tion of HMCs with replication-defective adenoviruses
containing a RAP cDNA under control of the CMV
promoter provides an effective means for transient over-
expression of LRP-blocking RAP, which resulted in t-PA
levels that were twofold to threefold increased within
one day, an effect that persisted through seven days and
then slowly returned to baseline over the next few weeks.
Ad-RAP infection also increased t-PA accumulation in
IL-1– and TNF-–treated HMCs, thus compensating
for the decreased t-PA synthesis in HMCs under inflam-
matory conditions. These findings are further evidenceFig. 6. Effect of Ad-RAP infection on t-PA accumulation in the condi-
for an important role of the t-PA degradative route intioned media of HMCs under inflammatory conditions. HMCs were
preincubated for one hour with 107 PFU/mL Ad-RAP ( ), 107 PFU/mL regulating the fibrinolytic capacity of the peritoneal cav-
Ad--Gal (), or vehicle (). Subsequently, the cells were incubated
ity and are relevant for developing methods to reducefor 24 hours in the absence or presence of 1000 U/mL TNF- or IL-1
(10 U/mL), and the conditioned media were assayed for the presence or prevent adhesion formation. The results also confirm
of t-PA antigen. Data shown are means  SD of three independent that mesothelial cells represent an attractive target for
experiments in duplicate. *P	 0.05 compared with corresponding non-
gene therapy.infected cells.
Adhesion formation is a serious, common, and costly
complication to surgery, and yet CAPD is devoid of
efficient means of control [4, 5, 26]. A reduced or at least
of control cells. In contrast, prior infection of HMCs
insufficient fibrinolytic capacity is assumed to be a central
with Ad--Gal showed only minor effects on the accumu-
denominator in the formation of adhesions. Because of
lation of t-PA in the conditioned media of HMCs under
the transient character of the provoking factors (sepsis,the various experimental conditions.
surgery, inflammation), this state of hypofibrinolytic ca-
pacity is also temporary. This suggests that intervention
DISCUSSION strategies to temporarily augment fibrinolytic capacity
in the peritoneal or other cavities also convey protectionIn a previous study, we showed that the addition of
against adhesion formation. Topical application of a re-exogenous RAP to HMCs prevents uptake and degrada-
combinant t-PA has been shown to reduce adhesion for-tion of t-PA via the LRP receptor on the mesothelial
mation in a variety of animal models [27]. However,surface [13]. However, RAP itself is also rapidly de-
t-PA injected intraperitoneally in rats rapidly disap-graded via uptake by the LRP receptor. The goal of
peared from the peritoneal cavity: After 24 hours, thethe present study was to explore the feasibility of using
adenovirus technology to overexpress the RAP gene in totally recovered t-PA represented 1/104 of the adminis-
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tered dose [28]. Thus, to increase fibrinolytic capacity in gene transfer might thus serve as a useful therapeutic
the abdominal cavity for an extended period of time, adjunct to present anti-adhesive strategies.
t-PA has to be administered in a slow release system.
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ample, inflammatory episodes. Although it remains to
Abbreviations used in this article are: Ad--Gal, adenoviral vectorsbe established whether the results of the present study
expressing the -galactosidase gene; Ad-RAP, adenoviral vectorswith cultured HMCs can be extrapolated to the more expressing the receptor-associated protein gene; BSA, bovine serum
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